Northbrook, Illinois
United States
3
2023-06-22
2
2021-06-01
These are the the leading inventors for applications assigned to onCOUR Pharma, Inc.:
onCOUR Pharma, Inc. based in Northbrook, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
#2 | 2019-04-04 ✅ Patent 11,020,424 granted on 2021-06-01Modified immune-modulating particles
#3 | 2019-02-28 ✅ Patent 11,045,492 granted on 2021-06-29Immune-modifying nanoparticles for the treatment of inflammatory diseases
Also check out onCour Pharma, Inc.'s (Northbrook, United States) applicant profile with 4 patent applications submitted.
338423 ⎘